Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study
- K. Y. Look
- , J. A. Blessing
- , C. M. Michener
- , S. C. Rubin
- , P. T. Ramirez
- , Denise Mackey
- Indiana University
- Eli Lilly and Company
- Roswell Park Cancer Institute
- Cleveland Clinic Foundation
- University of Pennsylvania
- University of Texas MD Anderson Cancer Center
- GOG Administrative Office
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations